The 20 Best Angiosarcoma Doctors Near Me in Boston, MA

Steven Come is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Come is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Come is board certified in American Board Of Internal Medicine.

Alphonse Taghian is a Radiation Oncologist practicing medicine in Boston, Massachusetts. Dr. Taghian is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, and Intraductal Papilloma. Dr. Taghian is board certified in Radiation Oncology.

Dr. Nakhlis received her medical degree from Rush Medical College in Chicago in 1996. She subsequently completed her residency in general surgery and her breast surgery fellowship at Northwestern University in Chicago. She is an attending physician in the Brigham and Women's Hospital and Brigham and Women’s Faulkner Hospital in Boston and an assistant professor of surgery at Harvard Medical School. Her clinical research interests are focused on lobular neoplasia and other premalignant and proliferative breast lesions, and inflammatory breast cancer. Dr. Nakhlis is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Nakhlis is board certified in Surgery, General.

Dr. Poorvu received his medical degree from the University of Pennsylvania in 2012 and went on to complete his residency in internal medicine at the Brigham and Women's Hospital. He is a medical oncologist in the Breast Oncology Center and has a particular interest in the care of young women with breast cancer and breast cancer survivorship. His research seeks to better understand the impact of cancer treatments on fertility and a number of other survivorship issues. Dr. Poorvu's research is also focused on the use of genomic risk prediction assays and predictive biomarkers to help guide the management of breast cancer patients. Dr. Poorvu is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Poorvu is board certified in Internal Medicine and Medical Oncology.

Dr. Suniti N. Nimbkar is a surgeon at Brigham and Women’s Hospital (BWH) , the medical director for the Breast Care Center at South Shore Hospital, in clinical affiliation with the Dana-Farber Brigham Cancer Center, and an instructor in surgery at Harvard Medical School.Dr. Nimbkar received her medical degree from Boston University School of Medicine and then completed a surgery residency at Boston University Medical Center (now Boston Medical Center). She is board certified in general surgery.Dr. Nimkar’s clinical and research interests include benign breast disease, breast conservation surgery, mastectomy with immediate reconstruction, nipple-sparing mastectomy, pregnancy-associated breast cancer and sentinel lymph node biopsy. Dr. Nimbkar is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Lymphadenectomy, and Mastectomy. Dr. Nimbkar is board certified in Surgery, General.

Susan Schumer is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Schumer is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Schumer is board certified in Medical Oncology.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Partridge is board certified in Medical Oncology.

Nadine Tung is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Tung is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Tung is board certified in American Board Of Internal Medicine.

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011. She completed residency training in internal medicine at Brigham and Women's Hospital, where she subsequently served an additional year as a Chief Resident in Internal Medicine. She completed fellowship training in medical oncology at Dana-Farber/Partners CancerCare, then joined the staff of the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Waks is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Waks is board certified in Internal Medicine and Medical Oncology.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology.

Ranjna Sharma is a Surgical Oncologist and a General Surgeon practicing medicine in Needham, Massachusetts. Dr. Sharma is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Mastectomy, and Lymphadenectomy. Dr. Sharma is board certified in American Board Of Surgery.

Dr. Jennifer Ligibel is a Professor at Harvard Medical School, the Director of the Leonard P. Zakim Center for Integrative Therapies and Healthy Living, and the Director of the Center for Faculty Well-Being at the Dana-Farber Cancer Institute. Dr. Ligibel’s research focuses on the impact of lifestyle interventions upon cancer-related outcomes in women with breast cancer. She has conducted a number of studies looking at the impact of exercise and weight loss interventions upon patients’ quality of life and symptoms after cancer diagnosis and is currently leading an NCI-funded Phase III clinical trial that will test the impact of a weight loss intervention upon the risk of disease recurrence in more than 3000 overweight and obese women with early-stage breast cancer. Dr. Ligibel was the Chair of the American Society of Clinical Oncology Subcommittee on Energy Balance, which has developed patient and physician materials to help facilitate healthy lifestyle changes after cancer diagnosis. Dr. Ligibel is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Hormone Replacement Therapy (HRT). Dr. Ligibel is board certified in Medical Oncology.

Kelly Downey is an Internal Medicine provider practicing medicine in Needham, Massachusetts. Dr. Downey is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Paget Disease of the Breast, Pancreatic Ductal Adenocarcinoma, and Inflammatory Breast Cancer. Dr. Downey is board certified in American Board Of Internal Medicine.

Saritha Bolla is an Internal Medicine specialist and an Oncologist practicing medicine in Winchester, Massachusetts. Dr. Bolla is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer. Dr. Bolla is board certified in American Board Of Internal Medicine.

Robyn Sachs is a General Surgeon practicing medicine in Plymouth, Massachusetts. Dr. Sachs is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Sachs is board certified in American Board Of Surgery.

Gerburg Wulf is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Wulf is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT). Dr. Wulf is board certified in American Board Of Internal Medicine.

Barbara Smith is a General Surgeon and a Surgical Oncologist practicing medicine in Boston, Massachusetts. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Smith is board certified in Surgery, General.

Laura Spring is an Oncologist practicing medicine in Danvers, Massachusetts. Dr. Spring is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Bone Marrow Transplant. Dr. Spring is board certified in Medical Oncology.

Jennifer Shin is an Oncologist practicing medicine in Danvers, Massachusetts. Dr. Shin is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Shin is board certified in Hospice And Palliative Medicine and Medical Oncology.

Dr. Esther Rhei a surgeon at Brigham and Women’s Hospital (BWH), Brigham and Women’s Faulkner Hospital and Dana-Farber Brigham Cancer Center, and an assistant professor of surgery at Harvard Medical School. Dr. Rhei received her medical degree from Rutgers Robert Wood Johnson Medical School. She then completed a general surgery residency at State University of New York Health Science Center at Brooklyn and a fellowship at Memorial Sloan Kettering Cancer Center. Dr. Rhei is board certified in surgery. Her clinical and research interests include benign breast disease, breast cancer, and decision making in breast cancer surgery. She has received numerous teaching awards from Harvard Medical School and the Department of Surgery. Dr. Rhei has been named to Marquis Who's Who in the World, America's Top Doctors by Castle Connolly, and Top Doctor in Boston Magazine since 2012. Dr. Rhei is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy. Dr. Rhei is board certified in Surgery, General.